EMA accepts Astellas, Seagen's enfortumab vedotin application in urothelial cancer
March 26 2021 - 2:04AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Apr 2024 to May 2024
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From May 2023 to May 2024